Your browser doesn't support javascript.
loading
When and How To Use Endoscopic Tattooing in the Colon: An International Delphi Agreement.
Medina-Prado, Lucía; Hassan, Cesare; Dekker, Evelien; Bisschops, Raf; Alfieri, Sergio; Bhandari, Pradeep; Bourke, Michael J; Bravo, Raquel; Bustamante-Balen, Marco; Dominitz, Jason; Ferlitsch, Monika; Fockens, Paul; van Leerdam, Monique; Lieberman, David; Herráiz, Maite; Kahi, Charles; Kaminski, Michal; Matsuda, Takahisa; Moss, Alan; Pellisé, Maria; Pohl, Heiko; Rees, Colin; Rex, Douglas K; Romero-Simó, Manuel; Rutter, Matthew D; Sharma, Prateek; Shaukat, Aasma; Thomas-Gibson, Siwan; Valori, Roland; Jover, Rodrigo.
Affiliation
  • Medina-Prado L; Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.
  • Hassan C; Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy.
  • Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands.
  • Bisschops R; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
  • Alfieri S; Surgery Department, Fondazione Policlinico A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Bhandari P; Department of Gastroenterology, Queen Alexandra Hospital. Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom.
  • Bourke MJ; Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia.
  • Bravo R; Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, University of Barcelona, Centro Esther Koplowitz, Cellex
  • Bustamante-Balen M; Gastrointestinal Endoscopy Unit, Gastrointestinal Endoscopy Research Group, Health Research Institute (Instituto de Investigación Sanitaria La Fe. NHS: National Health Service), Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Dominitz J; Gastroenterology Department, VA Puget Sound Health Care System, University of Washington, Seattle, Washington.
  • Ferlitsch M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria.
  • Fockens P; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands.
  • van Leerdam M; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lieberman D; Division of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oregon.
  • Herráiz M; Departamento de Digestivo, Clínica Universitaria de Navarra, Pamplona, Spain.
  • Kahi C; Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, Indiana.
  • Kaminski M; Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland.
  • Matsuda T; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Moss A; Department of Endoscopic Services, Western Health, Melbourne Medical School Western Precinct, The University of Melbourne, St. Albans, Victoria, Australia.
  • Pellisé M; Gastroenterology Department, Institute of Digestive and Metabolic Diseases, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, University of Barcelona, Centro Esther Koplowitz, Cellex Biomedical
  • Pohl H; Department of Gastroenterology and Hepatology, VA Medical Center, White River Junction, Vermont; Dartmouth Geisel School of Medicine, Hanover, New Hampshire.
  • Rees C; Department of Gastroenterology, South Tyneside NHS Foundation Trust, South Shields, United Kingdom.
  • Rex DK; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Romero-Simó M; Unidad de Coloproctología, Servicio de Cirugía General, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.
  • Rutter MD; University Hospital of North Tees, Stockton on Tees, United Kingdom; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
  • Sharma P; Department of Gastroenterology and Hepatology, VA Medical Center, University of Kansas School of Medicine, Kansas City, Kansas.
  • Shaukat A; Section of Gastroenterology, Department of Medicine, Minneapolis VA Medical Center, University of Minnesota, Minneapolis, Minnesota.
  • Thomas-Gibson S; Wolfson Unit for Endoscopy, St. Mark's Hospital, Harrow, and Imperial College, London, United Kingdom.
  • Valori R; Gloucestershire Hospitals National Health Service Foundation Trust, Gloucestershire, United Kingdom.
  • Jover R; Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain. Electronic address: rodrigojover@gmail.com.
Clin Gastroenterol Hepatol ; 19(5): 1038-1050, 2021 05.
Article in En | MEDLINE | ID: mdl-33493699
ABSTRACT
BACKGROUND &

AIMS:

There is a lack of clinical studies to establish indications and methodology for tattooing, therefore technique and practice of tattooing is very variable. We aimed to establish a consensus on the indications and appropriate techniques for colonic tattoo through a modified Delphi process.

METHODS:

The baseline questionnaire was classified into 3 areas where tattooing should not be used (1 domain, 6 questions), where tattooing should be used (4 domains, 20 questions), and how to perform tattooing (1 domain 20 questions). A total of 29 experts participated in the 3 rounds of the Delphi process.

RESULTS:

A total of 15 statements were approved. The statements that achieved the highest agreement were as follows tattooing should always be used after endoscopic resection of a lesion with suspicion of submucosal invasion (agreement score, 4.59; degree of consensus, 97%). For a colorectal lesion that is left in situ but considered suitable for endoscopic resection, tattooing may be used if the lesion is considered difficult to detect at a subsequent endoscopy (agreement score, 4.62; degree of consensus, 100%). A tattoo should never be injected directly into or underneath a lesion that might be removed endoscopically at a later point in time (agreement score, 4.79; degree of consensus, 97%). Details of the tattoo injection should be stated clearly in the endoscopy report (agreement score, 4.76; degree of consensus, 100%).

CONCLUSIONS:

This expert consensus has developed different statements about where tattooing should not be used, when it should be used, and how that should be done.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Tattooing Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tattooing Limits: Humans Language: En Year: 2021 Type: Article